Track topics on Twitter Track topics that are important to you
The Global Point of Care Testing Market is accounted to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016; it is growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
The major factors driving the market for Global PointOfCare Testing Market, such as increasing geriatric population, increase in infectious diseases hepatitis, HIV infection, influenza, respiratory infections and others, technological advancements, introduction of homebased point of care devices, and rapid economic development in the emerging economies.
The key market players for Global Point of Care Testing Market are listed below:
Siemens AG and Abbott Laboratories, Inc.,
Beckman Coulter, Inc.,
Becton, Dickinson and Company,
AccuBioTech Co., Ltd.,
ACON Laboratories, Inc.,
Atlas Genetics Ltd.,
Alfa Scientific Designs, Inc.,
BioRad Laboratories, Inc.,
The market is further segmented into:
The global pointofcare testing market is segmented on the basis of product into prescription mode, distribution channel, end user, and geography.
On the basis of product, the market is segmented into 13 major segments, which includes blood glucose testing kits, cardio metabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Cardiometabolic Monitoring Kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing.
Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexuallytransmitted diseases testing kits, tropical diseases testing kits, healthcareassociated infections, and respiratory infections testing kit.
Based on prescription mode, the global pointofcare testing market is segmented into prescription based testing and overthecounter OTC testing.
On the basis of distribution channel, the market is segmented into direct tenders and retail. In 2017, the direct tender market is expected to dominate the market with a share of 64.0% in the forecast period 20172024.
On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.
Based on geography, the Global Point of Care Testing market is segmented into 11 geographical regions, such as,
Covered in this report
The report covers the present scenario and the growth prospects of the Global Point of Care Testing market for 20172021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration UCC and video conferencing, secondary resources and doing indepth company share analysis of major 10 players in the market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.NEXT ARTICLE
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...
AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...